Clinical Trial: Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923591) titled 'Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)' on Oct. 19.

Brief Summary: The primary purpose of this study is to evaluate the safety and tolerability of treprostinil administered with a soft mist inhaler (SMI) over 16 weeks in approximately 40 participants with PH-COPD.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease

Intervention: COMBINATION_PRODUCT: treprostinil SMI (treprostinil inhalation spray)

Inhaled t...